key: cord-1031937-3qfloz1d
authors: Karam, M.; Althuwaikh, S.; Alazemi, M.; Abul, A.; Hayre, A.; Gavin, B.
title: Chest CT versus RT-PCR for the Detection of COVID-19: Systematic Review and Meta-Analysis
date: 2020-06-23
journal: nan
DOI: 10.1101/2020.06.22.20136846
sha: 260b0f08d429b29d586f49839437b45561683e6e
doc_id: 1031937
cord_uid: 3qfloz1d

Objectives To compare the performance of chest computed tomography (CT) scan versus reverse transcription polymerase chain reaction (RT-PCR) in the initial diagnostic assessment of coronavirus disease 2019 (COVID-19) patients. Methods A systematic review and meta-analysis were performed as per the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. A search of electronic information was conducted to identify studies comparing the diagnostic performance within the same patient cohort of chest CT scan versus RT-PCR in COVID-19 suspected cases. Sensitivity, specificity and accuracy were primary outcome measures. Secondary outcomes included other test performance characteristics, discrepant findings between both investigations and main chest CT findings. Random effects modelling was used for the analyses. Results Thirteen non-randomised studies enrolling 4092 patients were identified. Accuracy was statistically significantly higher for RT-PCR versus chest CT (Odds Ratio [OR] = 0.22, P = 0.001). Chest CT is also less specific than RT-PCR. Ground-glass opacities and consolidations were the most common chest CT manifestations. Importantly, early small studies tended to favour chest CT versus later larger studies. Conclusion Chest CT is inferior to RT-PCR for the initial detection of COVID-19 and has more false positives. It may still be useful in confirming COVID-19, however, in patients with a suspicious clinical presentation, but who have a false-negative SARS-CoV-2 RT-PCR test.

In December 2019, Coronavirus Disease 2019 , caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) emerged from Wuhan city, Hubei province, China 1,2 . SARS-COV-2 is part of the Coronavirdae family that includes the common cold, Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS). These viruses can cause Acute Respiratory Distress Syndrome (ARDS), bilateral pneumonia and pulmonary failure leading to mortality 3 . There is yet to be a highly effective pharmacological therapy identified for COVID-19, further highlighting the importance of early detection and isolation of COVID-19 patients to prevent the spread of the disease 4 .

Reverse-transcription polymerase chain reaction (RT-PCR) tests are currently the gold standard diagnostic tool for COVID-19. RT-PCR assays can be performed on nasopharyngeal and/or oropharyngeal swabs, sputum, blood samples, body fluids, stool samples and bronchoalveolar lavage fluid 5 . RT-PCR is limited by its low sensitivity and associated relatively high number of false-negative results that can lead to the erroneous assumption that a patient who does actually have COVID-19 is not infectious, and thus leading to an undetected transmission risk in either the community or within an institutional setting 4 .

CT has become a standard of care in the diagnosis and assessment of a variety of respiratory conditions, such as interstitial lung disease and lung cancer, and optimises the management process 6, 7 . Although CT scans are not routinely used to diagnose ARDS, certain complications that appear relating to mechanical ventilation, including pneumonia, pneumothorax and emphysema, are sometimes identified by CT but not chest radiography 8 . In addition, CT imaging can be used to identify lung atelectasis due to poor positioning of the endotracheal tube as well as potentially directing ventilation to achieve optimal pressures and air recruitment 8 . This is important in relation to COVID-19 since patients in ICU require optimisation of ventilatory settings and it is increasingly recognised that prone ventilation appears favourable 9 . Nevertheless, in the clinical setting, the benefits of routine CT imaging must be weighed against the considerable practicalities and risks, . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 23, 2020. . https://doi.org/10.1101/2020.06. 22.20136846 doi: medRxiv preprint including that of infection transmission associated with transporting a patient from the intensive care unit, or elsewhere in the hospital, to the radiology department 8 . The Royal College of Radiologists does not recommend the use of CT-scanning as a diagnostic tool for COVID-19, as a negative CT finding does not rule out COVID-19 infection, except for when CT-scanning results can change the management course such as those who require emergency surgery 10 . Furthermore, both the American Society of Emergency Radiology and the Society of Thoracic Radiology advise against the use of CT-scanning as a diagnostic tool for COVID-19 11 . They also recommend restricting the use of CT-scanning for confirmed and the highly suspected cases of COVID-19 when scanning can help manage complications such as patients with lung abscess 11 .

Given the recent non-randomised studies comparing chest CT and RT-RCR in detecting COVID-19 cases 4,12-18 , there is a need for ongoing systematic reviews and meta-analyses. This study aimed to compare the outcomes of chest CT-scan versus RT-PCR for the diagnosis of COVID-19 by systematic review of comparative studies (i.e. studies that have directly compared the performance of the two tests in the same patient cohort).

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 23, 2020. 

A systematic review and meta-analysis were conducted as per the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines 19 .

All relevant studies comparing chest CT with RT-PCR in the diagnosis of patients with suspected COVID-19 were included 4, [12] [13] [14] [15] [16] [17] [18] . Chest CT was the intervention group of interest and RT-PCR was the comparator. All patients were included irrespective of age, gender or co-morbidity status.

Studies that did not compare the two tests directly within the same patient cohort were excluded.

Studies enrolling only confirmed COVID-19 cases or studies performing chest CT for prognostic rather than diagnostic purposes were also excluded.

Sensitivity, specificity and accuracy for the diagnosis of COVID-19 cases were the primary outcomes. Sensitivity (true positive rate) is the proportion of actual COVID-19 cases a test correctly identifies. Specificity (true negative rate) is the proportion of non-COVID-19 cases a test correctly identifies. Accuracy is the proportion (true positives and true negatives) of total cases examined a test correctly identifies.

The secondary outcomes were positive predictive value (in the event of a positive test the probability the patient is truly positive), negative predictive value (in the event of a negative test the probability the patient is truly negative), positive (PLR) and negative likelihood (NLR) ratios (respectively, the probability a person who has COVID-19 testing positive divided by the probability of a person who does not have COVID-19 testing positive [PLR] and the probability of a person who has COVID-19 testing negative divided by the probability of a person who does not have COVID-19

testing negative [NLR] ) and discrepancy of findings between both investigations as well as main chest CT findings.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 23, 2020. terminologies included "COVID-19", "Coronavirus", "SARS-CoV-2", "severe acute respiratory syndrome coronavirus 2", "CT", "computed tomography", "RT-PCR", "Reverse transcription polymerase chain reaction", "PCR" and "polymerase chain reaction". The bibliographic lists of relevant articles were also reviewed.

The title and abstract of articles identified from the literature searches were assessed independently by two authors. The full texts of relevant reports were retrieved and those articles that met the eligibility criteria of our review were selected. Any discrepancies in study selection were resolved by discussion between the authors.

An electronic data extraction spreadsheet using Microsoft Excel was created in line with Cochrane's data collection form for intervention reviews. The spreadsheet was pilot tested in randomly selected articles and adjusted accordingly. The data extraction spreadsheet included study-related data (first author, year of publication, country of origin of the corresponding author, journal in which the study was published, study design, study size, clinical condition of the study participants, type of intervention, and comparison), baseline demographics of the included populations (age and gender) and primary and secondary outcome data. Three authors . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 23, 2020. . https://doi.org/10.1101/2020.06.22.20136846 doi: medRxiv preprint cooperatively collected and recorded the results and any disagreements were resolved via discussion.

Data synthesis was conducted using the Review Manager 5.3 software and Microsoft Excel.

The extracted data was entered into Review Manager by two independent authors. The analysis used was based on the random effect model. The results are reported in forest plots with 95% Confidence Intervals (CIs).

For dichotomous outcomes, the Odds Ratio (OR) was calculated between the 2 groups. The OR is the odds of an event in the chest CT group compared with the RT-PCR group. An OR of greater than 1 (with the lower 95% CI >1) for accuracy to detect or exclude COVID-19 cases favours Chest CT, an OR of less than 1 (with the upper 95% CI <1) favours RT-PCR, and an OR of 1 (with the 95% CIs bridging 1) favours neither. Pooled mean sensitivity and specificity values were generated. Summary receiver operator characteristic (sROC) curves were also generated with associated area under the receiver operating curves and 95% CIs.

Heterogeneity among the studies was assessed using the Cochran Q test (χ 2 ). Inconsistency was quantified by calculating I 2 and interpreted using the following guide: 0% to 25% may represent low heterogeneity, 25% to 75% may represent moderate heterogeneity, and 75% to 100% may represent high heterogeneity.

To identify areas of heterogeneity and assess the robustness of our results in studies with certain characteristics, additional sensitivity and sub-group analyses were performed.

Two authors independently assessed the methodological quality as well as the risk of bias for articles matching the inclusion criteria. The Newcastle-Ottawa Scale 20 was used to assess the quality of included studies, which uses a star system for analyses. It offers a maximum score of nine . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 23, 2020. . https://doi.org/10.1101/2020.06.22.20136846 doi: medRxiv preprint stars across three domains including selection, comparability and exposure. The overall rating of good, fair or poor quality was based on the Agency for Healthcare Research and Quality (AHRQ) standards 20 . A third author was used as an adjudicator if consensus was required.

Our search strategy retrieved 944 studies. Eight studies met the eligibility criteria for inclusion following systematic review 4,12-18 ( Figure 1 ).

The baseline characteristics of the included studies are summarised in Table 1 . All included studies were comparative with CT scans being assessed using RT-PCR as the reference.

Ai et al. 4 conducted a single centre retrospective study that included 1014 patients (the largest study included) with suspected COVID-19 from January 6 to February 6, 2020. RT-PCR and chest CT results were obtained from medical records and three CT systems with all chest CT images reviewed by two radiologists.

Caruso et al. conducted a single centre prospective cohort study that enrolled a total of 158 study participants that underwent both RT-PCR and chest CT due to COVID-19 suspicion from March 4, 2020 to March 19, 2020. Two experienced radiologists reviewed all chest CT images.

Fang et al. 13 performed a single centre retrospective study that included 51 patients with suspected COVID-19 from January 19 to February 4, 2020. All included patients underwent chest CT and RT-PCR testing within an interval of three days or less.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 23, 2020. 14 Gietema et al. 14 conducted a single centre prospective study that included 193 symptomatic emergency department patients, who were suspected of having COVID-19, between March 13 th and March 24 th , 2020. All patients had a chest CT and RT-PCR test upon arrival to the emergency department. Data were collected from medical records and CT scan results compared to that of RT-PCR. The initial judgment of CT scans was performed by a senior resident and the final reading and reporting was performed by an experienced chest radiologist within 12 hours of scanning.

3.2.5. He et al. 15 He et al. 15 performed a single centre retrospective study of 82 patients who were suspected to have COVID-19 between January 10 th and February 28 th , 2020. All patients underwent both RT-PCR and chest CT-scan testing. Interpretation and final diagnosis of the CT imaging was completed by two trained radiologists.

3.2.6. Long et al. 16 Long et al. 16 performed a single centre retrospective study that included 87 patients with suspected COVID-19 patients between January 20 th , 2020 and February 8 th , 2020. All patients underwent a CT scan and RT-PCR. All lesions identified on chest CT images were predefined and reviewed by two radiologists.

Ma et al. 17 conducted a single centre retrospective study enlisting 158 children under the age of 17 who had a social or family exposure to COVID-19, from January 21 st to February 14 th , 2020.

RT-PCR was initial performed with a follow up chest CT scan to evaluate lung pathology. Data was collected through access to patients' electronic medical records. CT scan results were assessed by two independent radiologists with at least a decade's worth of experience. If there was a discrepancy in the diagnosis from the CT scans, consensus was reached by discussion.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 23, 2020. 18 Xie et al. 18 reported a single centre retrospective study that included 167 patients with highrisk COVID-19 cases. All available data, including clinical history, laboratory and epidemic characteristics, were collected. Two blinded radiologists independently reviewed the CT images. (Table 2 and Table 3 ).

Specificity in identifying COVID-19 was reported in six studies enrolling 1692 patients 4, 13 ( Figure 2 ). The specificity for chest CT was lower than that of RT-PCR in the identification of COVID-19 cases, with mean specificity values of 0.70 and 1.00, respectively ( Table 2 and Table 3 ).

Overall, CT and RT-PCR have similar discriminatory power in identifying patients with COVID-19 from non-infected patients (Figure 3 ).

Accuracy to detect and exclude COVID-19 cases was reported in eight studies enrolling 1910 patients 4,12-18 ( Figure 4 ). There was no statistically significant difference in the identification and exclusion of COVID-19 cases (OR = 0.40, CI = 0.12 to 1.39, P = 0.15), although the statistical trend favoured RT-PCR over CT. There was a high level of heterogeneity between studies (I 2 = 86%, P < 0.00001).

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 23, 2020. Other test performance characteristics are summarised in Table 2 and Table 3 . CT scan had a lower positive predictive value, calculated from all studies 4, 12-18 , than RT-PCR, with mean values of 0.81 and 1.0 respectively. Conversely, the mean negative predictive value, calculated from Ai et al. 4 and Long et al. 16 , was slightly higher for CT scan (0.91) versus RT-PCR (0.86). Additionally, the NLR, calculated from Ai et al. 4 and Long et al. 16 , was lower for CT scan versus RT-PCR, with mean values of 0.14 and 0.22, respectively. Comparison between PCR and CT for PLR was impossible due to incomplete data.

Ai et al. 4 (Table 4 ). 81% (42/52) of patients who initially had a negative PCR but then had a positive PCR later had a CT scan suggestive of COVID-19 (Table 4 ).

According to Fang et al. 13 (n = 51), typical manifestations, such as peripheral, subpleural ground-glass opacities, usually in the lower lobes, were seen in 72% of detected cases by CT scan; atypical manifestations were found in 28% of cases. Caruso et al. 12 (n = 158) further highlighted that ground glass opacities (100%) with multi-(93%) and posterior (93%) lobe involvement, and bilateral distribution (91.4%) were the most common manifestations in COVID-19 cases confirmed by PCR.

Similarly, Long et al. 16 (n = 87) found the commonest CT pattern in their cohort of COVID-19 cases was ground-glass opacities with consolidations (52.7%) in the lower lobes. Ma et al. 17 (n = 158) also reported that the most common manifestation was ground-glass opacities (58%). However, Ai et al. 4 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 23, 2020. . https://doi.org/10.1101/2020.06.22.20136846 doi: medRxiv preprint (n = 1014) found that consolidation and ground-glass opacities were reported in 50% and 46% of cases respectively.

Sensitivity analyses were performed for the accuracy of CT scan and RT-PCR to identify and exclude COVID-19 cases. There was no change in the direction of the effect size and the overall heterogeneity when one study was removed at a time. However, when Fang et al. 2020 was removed the trend towards favouring of RT-PCR reached statistical significance. When the odds ratios, risk ratios and risk differences were calculated separately, there was no change in the direction of the effect size. There was similarly no change in the direction of the effect sizes when using the random or fixed effects models. Nevertheless, when using the fixed effect model, the trend towards favouring of R0T-PCR reached statistical significance.

There was a statistically significant difference between China versus Europe-based subgroups in terms of accuracy in the identification of COVID-19 (P <0.0001); Figure 5 . In China based studies there was no statistical difference between RT-PCR and CT scan (OR = 0.97, CI = 0.34 to 2.73, P = 0.95). In comparison, Europe based studies showed RT-PCR to be statistically significantly more accurate than CT (OR = 0.40, CI = 0.12 to 1.39, P < 0.0001).

There was also a statistically significant difference between larger (n ≥100) and smaller (n <100) study subgroups in accuracy for the identification COVID-19 (P = 0.01); Figure 6 . Larger studies showed that RT-PCR is more accurate than CT scan with a statistically significant difference (OR = 0.08, CI = 0.01 to 0.57, P = 0.01). Smaller studies suggested no difference in accuracy between the two tests (OR = 3.90, CI = 0.38 to 40.45, P = 0.25).

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 23, 2020. . https://doi.org/10.1101/2020.06.22.20136846 doi: medRxiv preprint

There was a statistically significant difference between adult or mixed age versus childrenbased subgroups in accuracy for the identification of COVID-19 (P = 0.01). Adult or mixed age-based studies suggested no difference in accuracy between RT-PCR and CT scan (OR = 0.60, CI = 0.18 to 1.97, P = 0.40). Children-based studies favoured PCR with statistical significance (OR = 0.01, CI = 0.00 to 0.19, P = 0.002).

Although comparability was low in all studies 4,12-18 , selection and exposure were of higher quality (Table 5) . Overall, all studies were of good quality based on the AHRQ standards 16 .

Our findings suggest that chest CT performs similarly to RT-PCR in the initial detection of COVID-19 in the clinical context of the studies presented (i.e. hospitalised patients within a pandemic). CT had a slightly higher sensitivity (lower false negatives), but lower specificity (higher false positives) than RT-PCR. There was no statistical difference in the accuracy of CT when compared to RT-PCR for the identification and exclusion of COVID-19 cases (P = 0.15). The performance characteristics of all tests is context dependent, however, which means that the performance of CT for identifying COVID-19 will be different outside of a pandemic and in areas of the world with different endemicities. When the causes of bilateral CT changes return to the usual heterogeneous state, with SARS-CoV-2 only one of many potential causes, as was the situation prepandemic, the performance of CT will likely deteriorate with an even higher number of false positives, in keeping with the relatively modest PLR for CT, even within a pandemic setting, based on the study of Ai et al. 4 For patients requiring hospitalisation with an acute cardio-respiratory presentation, a negative CT scan will likely remain reassuring, particularly if RT-PCR is also negative . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 23, 2020. . https://doi.org/10.1101/2020.06. 22.20136846 doi: medRxiv preprint in keeping with the lower NLRs for CT versus RT-PCR. Our results cannot be extrapolated to healthier SARS-CoV-2 patient cohorts who are managed on an outpatient basis or in a community setting.

Diagnostic tests always have inherent strengths and weaknesses. In the case of the COVID-19 pandemic it would be preferable to have a simple test with high sensitivity leading to a low number of false negatives thereby allowing accurate decision-making regarding, for example, who may be infectious and requires isolation in the hospital setting or home isolation in the community.

Based on those who had a suggestive CT but tested negative with RT-PCR, our findings suggest that CT scan may be able to detect a greater proportion of COVID-19 cases overall and may be useful when PCR testing is initially negative but clinical suspicion high 4 . There were relatively few patients who had a negative CT scan, but who were initially RT-PCR positive. Of the studies that reported patients who were initially RT-PCR negative, but subsequently became positive, 8 out of 10 patients had a suggestive CT. It is important to note that across the studies, however, only a small proportion who were initially RT-PCR negative were systematically retested.

Our results suggest that chest CT scan is not superior than RT-PCR in the initial detection of COVID-19, which supports published guidance and thus we do not advocate routine use. CT scans are subject to their inherent limitations. Firstly, they are best avoided during pregnancy due to the excessive radiation and risk of harming the foetus 21 . In addition, over-scanning patients with suspected COVID-19 can increase the risk of incidental imaging findings and an unnecessary financial burden on the healthcare system 22 . Furthermore, the use of CT-scans for suspected cases is not practical since SARS-CoV-2 has a relatively high transmission rate; each CT machine needs to be sterilised after use, which can waste time and resources as well as overworking the radiology department in times of need and hence may result in delayed reporting of other potentially lifethreatening conditions. Lastly, with many countries having problems with providing their healthcare staff with sufficient personal protective equipment (PPE), sending suspected cases for a CT to confirm the diagnosis will unnecessarily consume PPE.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 23, 2020. . https://doi.org/10.1101/2020.06.22.20136846 doi: medRxiv preprint Given the above, and based on our results therefore, we suggest that chest CT is a useful supplementary diagnostic strategy for COVID-19 in patients with suspicious symptoms, but a negative RT-PCR test result. In such situations, a repeat upper respiratory tract RT-PCR, which is simple to do, rather than a CT scan is also worth considering, although in our clinical experience some patients with suspicious presentations are repeatedly negative or only positive on a third or fourth test. Lower respiratory tract specimens (i.e. sputum or bronchoalveolar lavage) are more likely to be positive, although most hospitalised patients are neither productive nor ventilated.

In the studies included, the most common manifestations of COVID-19 in chest CT scans were ground-glass opacities and consolidations 4, [12] [13] [16] [17] . Based on the evidence from previous coronavirus outbreaks, the use of CT-scans may have some clinical and prognostic importance. In MERS, lung radiographic changes such as ground-glass opacifications and consolidations tend to affect the lung bases and can be used as an independent prognostic factor; patients with pleural effusion or pneumothorax have a higher mortality risk 23, 24 . Up to 30% of COVID-19 patients develop ARDS, which cannot always be confirmed on chest X-ray, making CT-scans potentially useful in such circumstances 25, 26 . Comparing the imaging findings of COVID-19 to SARS, despite both having absent features of pleural effusion and lymphadenopathy, COVID-19 tends to cause consolidation in multiple lung zones versus SARS, which tends to cause unifocal involvement 4, [27] [28] .

This review provides a summary of the best available evidence using a systematic approach and evaluated the risk of bias of included studies 4,12-18 . Although Kim et al. 29 recently published a meta-analysis on this topic, many of the studies included were not comparative (i.e. the tests were not compared within the same patient cohorts). Kim et al. 29 reported pooled sensitivity to be higher in CT scan (Sensitivity = 94%, 95% CI = 91% to 96%, I 2 = 95%) than RT-PCR (Sensitivity = 89%, 95% CI = 81% to 94%, I 2 = 83%), which supports our findings. Our study synthesised comparative studies only, and also included additional recently published studies and those in preprint, so our results may more accurately represent how the investigations can be expected to perform and compare in routine clinical practice. Our study also constructed summary receiver operator characteristic curves . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 23, 2020. . https://doi.org/10.1101/2020.06.22.20136846 doi: medRxiv preprint that can overcome some of limitations of univariate pooled sensitivity and specificity analyses 30 .

However, the reported outcomes should be considered in the context of the inherent limitations.

Only eight non-randomised studies were identified enrolling a total of 1910 participants, which may not be enough to draw definite conclusions, and suggesting the need for further robust prospective research. The performance of molecular tests for SARS-CoV-2 is likely to improve over time.

Likewise, the use of, for example, machine learning algorithms to interpret chest CT scan appearances may more accurately confirm Covid-19 than human reporting in the future, and thereby decrease the false-positive rate of CT scanning that can be expected to increase as the pandemic wanes. Some included studies had incomplete data resulting in difficulty in comparing both interventions completely. Additionally, all but one study included a relatively small number of patients and the majority were of retrospective observational design, with all the associated caveats of such studies. It is likely that further large comparative, and possibly prospective, studies will be reported with further meta-analyses required. The between-study heterogeneity for outcomes was high for sensitivity and accuracy. Based on the data presented in the studies included, zero false positives with RT-PCR were assumed, which is unlikely to be the case in real-life, although published studies do suggest false positives are rare.

Our study synthesised the best available comparative evidence, using a systematic approach, for the identification of COVID-19 using RT-PCR versus chest CT 4,12-18 . Our results suggest that chest CT scan is not superior to RT-PCR in the initial detection of COVID-19 in hospitalised patients in the context of a pandemic. Because of the inherent limitations of CT, however, we suggest RT-PCR remains the primary diagnostic tool, but that chest CT be considered if there is a strong clinical suspicion of COVID-19 and a negative RT-PCR test result, providing infection prevention and control measures can be maintained. A negative CT scan is likely to be reassuring in a RT-PCR negative patient requiring hospitalisation for possible COVID-19.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 23, 2020. *** * *** Table 5 . Newcastle-Ottawa Scale to Assess the Quality of Non-Randomised Studies.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 23, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 23, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 23, 2020. . https://doi.org/10.1101/2020.06.22.20136846 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 23, 2020. . https://doi.org/10.1101/2020.06.22.20136846 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 23, 2020. . https://doi.org/10.1101/2020.06.22.20136846 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 23, 2020. . https://doi.org/10.1101/2020.06.22.20136846 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 23, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 23, 2020. . https://doi.org/10.1101/2020.06.22.20136846 doi: medRxiv preprint

Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges

COVID-19 infection: origin, transmission, and characteristics of human coronaviruses

Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases

China National Health Commission. Diagnosis and treatment of pneumonitis caused by new coronavirus (trial version 5)

High-resolution CT of interstitial lung disease: a continuous evolution. InSeminars in respiratory and critical care medicine

The role of high-resolution chest CT in the diagnosis of neuroendocrine cell hyperplasia of infancy-A rare form of pediatric interstitial lung disease. Respiratory medicine case reports

Thoracic Radiology. STR / ASER COVID-19 Position Statement

Chest CT features of COVID-19 in

Sensitivity of chest CT for COVID-19: comparison to RT-PCR

CT in relation to RT-PCR in diagnosing COVID-19 in the Netherlands: a prospective study. medRxiv

Diagnostic performance between CT and initial real-time RT-PCR for clinically suspected 2019 coronavirus disease (COVID-19) patients outside Wuhan, China. Respiratory Medicine

Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT?

A single-center, retrospective study of COVID-19 features in children: a descriptive investigation

Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annals of internal medicine

The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses

Body CT during pregnancy: utilization trends, examination indications, and fetal radiation doses

The clinical dilemma of incidental findings on the lowresolution CT images from SPECT/CT MPI studies

Middle East respiratory syndrome coronavirus (MERS-CoV) infection: chest CT findings

Well-aerated Lung on Admitting Chest CT to Predict Adverse Outcome in COVID-19 Pneumonia

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet

Severe acute respiratory syndrome: radiographic appearances and pattern of progression in 138 patients

Acute Middle East respiratory syndrome coronavirus: temporal lung changes observed on the chest radiographs of 55 patients

Diagnostic performance of CT and reverse transcriptasepolymerase chain reaction for coronavirus disease 2019: a meta-analysis

Application of summary receiver operating characteristics (sROC) analysis to diagnostic clinical testing. 7 Reflections on the future of gastroenterology-unmet needs